➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
McKinsey
Baxter
Merck
Express Scripts

Last Updated: June 24, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Pacritinib


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Pacritinib?

Pacritinib is an investigational drug.

There have been 28 clinical trials for Pacritinib. The most recent clinical trial was a Phase 2 trial, which was initiated on May 22nd 2020.

The most common disease conditions in clinical trials are Primary Myelofibrosis, Thrombocytosis, and Thrombocythemia, Essential. The leading clinical trial sponsors are CTI BioPharma, Covance, and Washington University School of Medicine.

There are two hundred and forty-eight US patents protecting this investigational drug and two international patents.

Recent Clinical Trials for Pacritinib
TitleSponsorPhase
Pacritinib for Biochemical Relapse After Definitive Treatment for Prostate CancerMedical College of WisconsinPhase 2
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative NeoplasmsNational Institutes of Health (NIH)Phase 2
Pacritinib in Relapsed/Refractory T-cell Lymphoproliferative NeoplasmsUniversity of Michigan Rogel Cancer CenterPhase 2

See all Pacritinib clinical trials

Clinical Trial Summary for Pacritinib

Top disease conditions for Pacritinib
Top clinical trial sponsors for Pacritinib

See all Pacritinib clinical trials

US Patents for Pacritinib

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pacritinib   Try Before You Buy Therapeutic uses of selected pyrrolopyrimidine compounds with anti-mer tyrosine kinase activity The University of North Carolina at Chapel Hill (Chapel Hill, NC)   Try Before You Buy
Pacritinib   Try Before You Buy Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor Pharmacyclics LLC (Sunnyvale, CA)   Try Before You Buy
Pacritinib   Try Before You Buy Methods for the treatment of HER2 amplified cancer Pharmacyclics LLC (Sunnyvale, CA)   Try Before You Buy
Pacritinib   Try Before You Buy Benzimidazole derivatives as bromodomain inhibitors Gilead Sciences, Inc. (Foster City, CA)   Try Before You Buy
Pacritinib   Try Before You Buy Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections EMORY UNIVERSITY (Atlanta, GA)   Try Before You Buy
Pacritinib   Try Before You Buy TYK2 inhibitors and uses thereof Nimbus Lakshimi, Inc. (Cambridge, MA)   Try Before You Buy
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pacritinib

Drugname Country Document Number Estimated Expiration Related US Patent
Pacritinib Australia AU2015244171 2034-04-11   Try Before You Buy
Pacritinib Australia AU2015244179 2034-04-11   Try Before You Buy
Pacritinib Canada CA2945128 2034-04-11   Try Before You Buy
Pacritinib Canada CA2945129 2034-04-11   Try Before You Buy
Pacritinib China CN106414451 2034-04-11   Try Before You Buy
Pacritinib China CN106459063 2034-04-11   Try Before You Buy
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
McKesson
Baxter
Merck
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.